Acylated piperidine derivatives as melanocortin-4 receptor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/55 (2006.01) A61K 31/454 (2006.01) A61K 31/4545 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2573714

Certain novel N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

Selon l'invention, certains nouveaux dérivés de la pipéridine n acylés sont des agonistes des récepteurs de la mélanocortine humaine et, en particulier, des agonistes sélectifs du récepteur de la mélanocortine 4 (MC-4R). Lesdits dérivés sont utilisés pour le traitement, la régulation ou la prévention de maladies et de troubles responsables de l'activation de la MC-4R, tels que l'obésité, le diabètes, le dysfonctionnement sexuel, notamment les troubles de l'érection et les troubles sexuels féminins.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acylated piperidine derivatives as melanocortin-4 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylated piperidine derivatives as melanocortin-4 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated piperidine derivatives as melanocortin-4 receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1986863

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.